Walter Paul Weber
Overview
Explore the profile of Walter Paul Weber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1875
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pfob A, Sidey-Gibbons C, Lee H, Tasoulis M, Koelbel V, Golatta M, et al.
Eur J Cancer
. 2020 Dec;
143:134-146.
PMID: 33307491
Background: Neoadjuvant systemic treatment elicits a pathologic complete response (pCR) in about 35% of women with breast cancer. In such cases, breast surgery may be considered overtreatment. We evaluated multivariate...
22.
Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba B, et al.
Cell Rep
. 2020 Sep;
32(10):108105.
PMID: 32905777
Circulating tumor cells (CTCs) are shed from solid cancers in the form of single or clustered cells, and the latter display an extraordinary ability to initiate metastasis. Yet, the biological...
23.
Haefliger S, Muenst S, Went P, Bihl M, Dellas S, Weber W, et al.
Mol Biol Rep
. 2020 Jun;
47(6):4917-4921.
PMID: 32474846
Tall cell carcinoma with reversed polarity (TCCRP) is a rare breast carcinoma with low malignant potential, initially named "breast tumor resembling the tall cell variant of papillary thyroid carcinoma", which...
24.
Zeindler J, Soysal S, Piscuoglio S, Ng C, Mechera R, Isaak A, et al.
Front Med (Lausanne)
. 2019 Oct;
6:200.
PMID: 31572728
Triple-negative breast cancer (TNBC) represents about 10-20% of all invasive breast cancers and is associated with a poor prognosis. The nectin cell adhesion protein 4 (Nectin-4) is a junction protein...
25.
Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al.
Cell
. 2019 Apr;
177(5):1330-1345.e18.
PMID: 30982598
Breast cancer is a heterogeneous disease. Tumor cells and associated healthy cells form ecosystems that determine disease progression and response to therapy. To characterize features of breast cancer ecosystems and...
26.
Szczerba B, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, et al.
Nature
. 2019 Feb;
566(7745):553-557.
PMID: 30728496
A better understanding of the features that define the interaction between cancer cells and immune cells is important for the development of new cancer therapies. However, focus is often given...
27.
Gkountela S, Castro-Giner F, Szczerba B, Vetter M, Landin J, Scherrer R, et al.
Cell
. 2019 Jan;
176(1-2):98-112.e14.
PMID: 30633912
The ability of circulating tumor cells (CTCs) to form clusters has been linked to increased metastatic potential. Yet biological features and vulnerabilities of CTC clusters remain largely unknown. Here, we...
28.
Vetter M, Landin J, Szczerba B, Castro-Giner F, Gkountela S, Donato C, et al.
Breast Cancer Res
. 2018 Nov;
20(1):141.
PMID: 30458879
Background: The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable in only a minority of patients with progressive...
29.
30.
Weber W, Tausch C, Hayoz S, Fehr M, Ribi K, Hawle H, et al.
Ann Surg Oncol
. 2018 Jun;
25(9):2632-2640.
PMID: 29948418
Background: Several studies and a meta-analysis showed that fibrin sealant patches reduced lymphatic drainage after various lymphadenectomy procedures. Our goal was to investigate the impact of these patches on drainage...